1. |
Desai SR, Hedayati V, Patel K, et al. Chronic aspergillosis of the lungs: unravelling the terminology and radiology. Eur Radiol, 2015, 25(10): 3100-3107.
|
2. |
Kosmidis C, Denning DW. The clinical spectrum of pulmonary aspergillosis. Thorax, 2014, 70(3): 270-277.
|
3. |
Patterson KC, Strek ME. Diagnosis and treatment of pulmonary aspergillosis syndromes. Chest, 2014, 146(5): 1358-1368.
|
4. |
Denning DW, Cadranel J, Beigelman-Aubry C, et al. Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management. Eur Respir J, 2016, 47(1): 45-68.
|
5. |
Godet C, Philippe B, Laurent F, et al. Chronic pulmonary aspergillosis: an update on diagnosis and treatment. Respiration, 2014, 88(2): 162-174.
|
6. |
Smith NL, Denning DW. Underlying conditions in chronic pulmonary aspergillosis including simple aspergilloma. Eur Respir J, 2011, 37(4): 865-872.
|
7. |
Denning DW, Pleuvry A, Cole DC. Global burden of chronic pulmonary aspergillosis as a sequel to pulmonary tuberculosis. Bull World Health Organ, 2011, 89(12): 864-872.
|
8. |
Denning DW, Pleuvry A, Cole DC. Global burden of chronic pulmonary aspergillosis complicating sarcoidosis. Eur Respir J, 2013, 41(3): 621-626.
|
9. |
Felton TW, Baxter C, Moore CB, et al. Efficacy and safety of posaconazole for chronic pulmonary aspergillosis. Clin Infect Dis, 2010, 51(12): 1383-1391.
|
10. |
Nam HS, Jeon K, Um SW, et al. Clinical characteristics and treatment outcomes of chronic necrotizing pulmonary aspergillosis: a review of 43 cases. Int J Infect Dis, 2010, 14(6): e479-e482.
|
11. |
Muldoon EG, Sharman A, Page I, et al. Aspergillus nodules; another presentation of chronic pulmonary aspergillosis. BMC Pulm Med, 2016, 16(1): 123.
|
12. |
Kang EY, Kim DH, Woo OH, et al. Pulmonary aspergillosis in immunocompetent hosts without underlying lesions of the lung: radiologic and pathologic findings. Am J Roentgenol, 2002, 178(6): 1395-1399.
|
13. |
Sagan D, Gozdziuk K. Surgery for pulmonary aspergilloma in immunocompetent patients: no benefit from adjuvant antifungal pharmacotherapy. Ann Thorac Surg, 2010, 89(5): 1603-1610.
|
14. |
Cadrane J, Philipp B, Hennequi C, et al. Voriconazole for chronic pulmonary aspergillosis: a prospective multicenter trial. Eur J Clin Microbiol Infect Dis, 2012, 31(11): 3231-3239.
|
15. |
Nakamoto K, Takayanagi N, Kanauchi T, et al. Prognostic factors in 194 patients with chronic necrotizing pulmonary aspergillosis. Intern Med, 2013, 52(7): 727-734.
|
16. |
Jung SW, Kim MW, Cho SK, et al. A case of endobronchial aspergilloma associated with foreign body in immunocompetent patient without underlying lung disease. Tuberc Respir Dis (Seoul), 2013, 74(5): 231-234.
|
17. |
Sridhar V, Rajagopalan N, Shivaprasad C, et al. Acute community acquired Aspergillus pneumonia in a presumed immunocompetent host. BMJ Case Rep, 2012, 2012.
|
18. |
Ergene U, Akcali Z, Ozbalci D, et al. Disseminated aspergillosis due to Aspergillus niger in immunocompetent patient: a case report. Case Rep Infect Dis, 2013, 2013: 385190.
|
19. |
Latge JP. Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev, 1999, 12(2): 310-350.
|
20. |
Russell K, Broadbridge C, Murray S, et al. Gardening can seriously damage your health. Lancet, 2008, 371(9629): 2056.
|
21. |
Jung N, Mronga S, Schroth S, et al. Gardening can induce pulmonary failure: Aspergillus ARDS in an immunocompetent patient, a case report. BMC Infect Dis, 2014, 14(1): 600.
|
22. |
Aspergilloma and residual tuberculous cavities--the results of a resurvey. Tubercle, 1970, 51(3): 227-245.
|
23. |
Sambatakou H, Pravica V, Hutchinson IV, et al. Cytokine profiling of pulmonary aspergillosis. Int J Immunogenet, 2006, 33(4): 297-302.
|
24. |
Kelleher P, Goodsall A, Mulgirigama A, et al. Interferon-gamma therapy in two patients with progressive chronic pulmonary aspergillosis. Eur Respir J, 2006, 27(6): 1307-1310.
|
25. |
Carvalho A, Pasqualotto AC, Pitzurra L, et al. Polymorphisms in toll-like receptor genes and susceptibility to pulmonary aspergillosis. J Infect Dis, 2008, 197(4): 618-621.
|
26. |
Vaid M, Kaur S, Sambatakou H, et al. Distinct alleles of mannose-binding lectin (MBL) and surfactant proteins A (SP-A) in patients with chronic cavitary pulmonary aspergillosis and allergic bronchopulmonary aspergillosis. Clin Chem Lab Med, 2007, 45(2): 183-186.
|
27. |
He Q, Li H, Rui Y, et al. Pentraxin 3 gene polymorphisms and pulmonary aspergillosis in chronic obstructive pulmonary disease patients. Clin Infect Dis, 2018, 66(2): 261-267.
|
28. |
Chen JC, Chang YL, Luh SP, et al. Surgical treatment for pulmonary aspergilloma: a 28 year experience. Thorax, 1997, 52(9): 810-813.
|
29. |
Park CK, Jheon S. Results of surgical treatment for pulmonary aspergilloma. Eur J Cardiothorac Surg, 2002, 21(5): 918-23.
|
30. |
Babatasi G, Massetti M, Chapelier A, et al. Surgical treatment of pulmonary aspergilloma: current outcome. J Thorac Cardiovasc Surg, 2000, 119(5): 906-912.
|
31. |
Demir A, Gunluoglu MZ, Turna A, et al. Analysis of surgical treatment for pulmonary aspergilloma. Asian Cardiovasc Thorac Ann, 2006, 14(5): 407-411.
|
32. |
Lee JG, Lee CY, Park IK, et al. Pulmonary aspergilloma: analysis of prognosis in relation to symptoms and treatment. J Thorac Cardiovasc Surg, 2009, 138(4): 820-825.
|
33. |
Kohno S, Izumikawa K, Ogawa K, et al. Intravenous micafungin versus voriconazole for chronic pulmonary aspergillosis: a multicenter trial in Japan. J Infect, 2010, 61(5): 410-418.
|
34. |
Jhun BW, Jeon K, Eom JS, et al. Clinical characteristics and treatment outcomes of chronic pulmonary aspergillosis. Med Mycol, 2013, 51(8): 811-817.
|
35. |
Denning DW, Riniotis K, Dobrashian R, et al. Chronic cavitary and fibrosing pulmonary and pleural aspergillosis: case series, proposed nomenclature change, and review. Clin Infect Dis, 2003, 37 Suppl 3: S265-S280.
|
36. |
Sambatakou H, Dupont B, Lode H, et al. Voriconazole treatment for subacute invasive and chronic pulmonary aspergillosis. Am J Med, 2006, 119(6): 527.e17-e24.
|
37. |
Ohba H, Miwa S, Shirai M, et al. Clinical characteristics and prognosis of chronic pulmonary aspergillosis. Respir Med, 2012, 106(5): 724-729.
|
38. |
Shoemark A, Ozerovitch L, Wilson R. Aetiology in adult patients with bronchiectasis. Respir Med, 2007, 101(6): 1163-70.
|
39. |
Li AM, Sonnappa S, Lex C, et al. Non-CF bronchiectasis: does knowing the aetiology lead to changes in management. Eur Respir J, 2005, 26(1): 8-14.
|
40. |
Tsang KW, Lam SK, Lam WK, et al. High seroprevalence of Helicobacter pylori in active bronchiectasis. Am J Respir Crit Care Med, 1998, 158(4): 1047-1051.
|
41. |
Guan WJ, Gao YH, Xu G, et al. Aetiology of bronchiectasis in Guangzhou, southern China. Respirology, 2015, 20(5): 739-748.
|
42. |
Camuset, J, Nunes, H, Dombret, MC, et al. Treatment of chronic pulmonary aspergillosis by voriconazole in nonimmunocompromised patients. Chest, 2007, 131(5): 1435-1441.
|
43. |
Chawla K, Kosaraju K, Rayasam S, et al. Clinico-microbiological profile of chronic pulmonary aspergillosis from a tertiary care centre in southern India. J Clin Diagn Res, 2013, 7(12): 2712-2715.
|
44. |
Camara B, Reymond E, Saint-Raymond C, et al. Characteristics and outcomes of chronic pulmonary aspergillosis: a retrospective analysis of a tertiary hospital registry. Clin Respir J, 2015, 9(1): 65-73.
|
45. |
Bulpa P, Dive A, Sibille Y. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease. Eur Respir J, 2007, 30(4): 782-800.
|
46. |
Guinea J, Torres-Narbona M, Gijon P, et al. Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome. Clin Microbiol Infect, 2010, 16(7): 870-877.
|
47. |
Xu H, Li L, Huang WJ, et al. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: a case control study from China. Clin Microbiol Infect, 2012, 18(4): 403-408.
|
48. |
Chen QK, Jiang GN, Ding JA. Surgical treatment for pulmonary aspergilloma: a 35-year experience in the Chinese population. Interact Cardiovasc Thorac Surg, 2012, 15(1): 77-80.
|